关注
Monica Patanè
Monica Patanè
U.O. Neuropatologia Istituto Neurologico Carlo Besta Milano
在 istituto-besta.it 的电子邮件经过验证
标题
引用次数
引用次数
年份
The MET Oncogene Is a Functional Marker of a Glioblastoma Stem Cell Subtype
F De Bacco, E Casanova, E Medico, S Pellegatta, F Orzan, R Albano, ...
Cancer research 72 (17), 4537-4550, 2012
1642012
B7-H3-redirected chimeric antigen receptor T cells target glioblastoma and neurospheres
D Nehama, N Di Ianni, S Musio, H Du, M Patané, B Pollo, G Finocchiaro, ...
EBioMedicine 47, 33-43, 2019
1262019
Effective immuno-targeting of the IDH1 mutation R132H in a murine model of intracranial glioma
S Pellegatta, L Valletta, C Corbetta, M Patanè, I Zucca, F Riccardi Sirtori, ...
Acta neuropathologica communications 3, 1-12, 2015
1262015
Constitutive and TNFα-inducible expression of chondroitin sulfate proteoglycan 4 in glioblastoma and neurospheres: Implications for CAR-T cell therapy
S Pellegatta, B Savoldo, N Di Ianni, C Corbetta, Y Chen, M Patané, C Sun, ...
Science translational medicine 10 (430), eaao2731, 2018
1202018
Interaction between ephrins/Eph receptors and excitatory amino acid receptors: possible relevance in the regulation of synaptic plasticity and in the pathophysiology of …
L Calo, C Cinque, M Patane, D Schillaci, G Battaglia, D Melchiorri, ...
Journal of neurochemistry 98 (1), 1-10, 2006
702006
Interactions between ephrin-B and metabotropic glutamate 1 receptors in brain tissue and cultured neurons
L Calo, V Bruno, P Spinsanti, G Molinari, V Korkhov, Z Esposito, M Patanè, ...
Journal of Neuroscience 25 (9), 2245-2254, 2005
402005
First ex vivo validation of a radioguided surgery technique with β-radiation.
ES Camillocci, M Schiariti, V Bocci, A Carollo, G Chiodi, M Colandrea, ...
Physica Medica 32 (9), 1139-1144, 2016
362016
High tumor mutational burden and T-cell activation are associated with long-term response to anti-PD1 therapy in Lynch syndrome recurrent glioblastoma patient
E Anghileri, N Di Ianni, R Paterra, T Langella, J Zhao, M Eoli, M Patanè, ...
Cancer Immunology, Immunotherapy 70, 831-842, 2021
272021
Altered function of the glutamate–aspartate transporter GLAST, a potential therapeutic target in glioblastoma
C Corbetta, N Di Ianni, MG Bruzzone, M Patanè, B Pollo, G Cantini, ...
International journal of cancer 144 (10), 2539-2554, 2019
272019
ERBB3 overexpression due to miR-205 inactivation confers sensitivity to FGF, metabolic activation, and liability to ERBB3 targeting in glioblastoma
F De Bacco, F Orzan, J Erriquez, E Casanova, L Barault, R Albano, ...
Cell Reports 36 (4), 2021
232021
Frequency of NFKBIA deletions is low in glioblastomas and skewed in glioblastoma neurospheres
M Patanè, P Porrati, E Bottega, S Morosini, G Cantini, V Girgenti, A Rizzo, ...
Molecular Cancer 12, 1-12, 2013
152013
Tumor-initiating cell frequency is relevant for glioblastoma aggressiveness
C Richichi, D Osti, M Del Bene, L Fornasari, M Patanè, B Pollo, F DiMeco, ...
Oncotarget 7 (44), 71491, 2016
142016
The β-radio-guided surgery: method to estimate the minimum injectable activity from ex-vivo test
A Russomando, M Schiariti, V Bocci, M Colandrea, F Collamati, ...
Physica Medica 58, 114-120, 2019
132019
Long and very-long-chain ceramides correlate with a more aggressive behavior in skull base chordoma patients
E La Corte, M Dei Cas, A Raggi, M Patanè, M Broggi, S Schiavolin, ...
International Journal of Molecular Sciences 20 (18), 4480, 2019
112019
Mutations targeting the coagulation pathway are enriched in brain metastases
C Richichi, L Fornasari, GEM Melloni, P Brescia, M Patanè, M Del Bene, ...
Scientific Reports 7 (1), 6573, 2017
102017
Deciphering the labyrinthine system of the immune microenvironment in recurrent glioblastoma: recent original advances and lessons from clinical immunotherapeutic approaches
E Anghileri, M Patanè, N Di Ianni, I Sambruni, M Maffezzini, M Milani, ...
Cancers 13 (24), 6156, 2021
92021
The search for molecular markers in a gene-orphan case study of a pediatric spinal cord pilocytic astrocytoma
C Martinelli, F Gabriele, F Manai, R Ciccone, F Novara, E Sauta, ...
Cancer Genomics & Proteomics 17 (2), 117-130, 2020
62020
mTORC1 promotes malignant large cell/anaplastic histology and is a targetable vulnerability in SHH-TP53 mutant medulloblastoma
V Conti, M Cominelli, V Pieri, AL Gallotti, I Pagano, M Zanella, ...
JCI insight 6 (23), 2021
52021
Gliomatosis cerebri (GC) or GC-like? A picture to be reconsidered in neuro-oncology based on large retrospective analysis of GC series
E Anghileri, C Schettino, B Pollo, M Farinotti, A Silvani, R Paterra, ...
Neurological Sciences 41, 2111-2120, 2020
52020
Constitutive and TNF-inducible expression of chondroitin sulfate proteoglycan 4 in glioblastoma and neurospheres: Implications for CAR-T cell therapy
S Pellegatta, B Savoldo, N Di Ianni, C Corbetta, Y Chen, M Patané, C Sun, ...
Sci. Transl. Med 10, 2018
42018
系统目前无法执行此操作,请稍后再试。
文章 1–20